BioCentury
ARTICLE | Financial News

Merrimack raises $28 million

May 4, 2004 7:00 AM UTC

Autoimmune company Merrimack (Cambridge, Mass.) raised $28 million in a series C round of venture financing led by Sorenson Development. Additional investors included Unilever; GTC (GTCB); Wharton Bio...